Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px
Document › Details

mySugr GmbH. (6/30/17). "Press Release: mySugr Joins the Roche family". San Diego, CA.

Organisations Organisation mySugr GmbH
  Today Roche (Group)
  Group Roche (Group)
  Organisation 2 Roche Diabetes Care AG
  Group Roche (Group)
Products Product mySugr app
  Product 2 glucose metering device
Index term Index term mySugr–Roche: investment, 201706 acquisition of remaining shares by Roche
Persons Person Westermann, Frank (mySugr 201706 CEO + Co-Founder)
  Person 2 Gmuender, Marcel (Roche 201706 Global Head Diabetes Care)

mySugr announced today that partner Roche is now the exclusive shareholder of mySugr GmbH. This partnership will accelerate mySugr’s international growth and enhance its focus on new diabetes technology. mySugr reported reaching more than one million users in May of 2017.

Founded by four passionate entrepreneurs, mySugr becomes the heart of Roche Diabetes Care’s new patient-centered digital health services. This alignment strengthens mySugr’s unmatched patient focus and unparalleled success. Both companies expect to be well-positioned for a rapidly changing diabetes marketplace.

“We started mySugr to solve our everyday problems and simplify diabetes therapy through smartphones,” said Frank Westermann, CEO & co-founder of mySugr, “The mySugr team has filled a gap for over a million loyal users so far, and with Roche’s diabetes expertise and global network, mySugr will become an indispensable companion for a hassle-free life.”

Roche Diabetes Care sees mySugr’s vision for the digitalization of diabetes care as a perfect fit for their evolving organization.

“It is very exciting to take our successful partnership with mySugr to the next level as it will constitute an integral part of our new, open digital health ecosystem centered around the needs of people with diabetes,” says Marcel Gmuender, Global Head of Roche Diabetes Care. “We are passionately working to redefine the way diabetes care is being provided so that people with diabetes are not only seamlessly connected to their caregivers but can experience relief from their daily routines while spending more time in their target range.”

Being a focal point for Roche Diabetes Care’s integrated digital health strategy, mySugr will remain a separate legal entity with an open platform for all diabetes devices and services used by people with diabetes.

About mySugr

Founded in 2012, mySugr specializes in all-around care for people with diabetes. Its apps and services beautifully combine diabetes coaching, therapy management, unlimited test-strips, automated data tracking, and seamless integration with a growing number of medical devices to ease the daily burden of living with diabetes. Early investors include business angel “Hansi” Hansmann, iSeed Ventures, and Roche Venture Fund. The company has offices in San Diego, California and Vienna, Austria with 47 employees across both locations. The mySugr App is available in 52 countries and 13 languages. For more information, please visit

About Roche Diabetes Care

Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 40 years, the Accu-Chek brand has been dedicated to enabling people with diabetes to live life as normally and actively as possible as well as to empowering healthcare professionals to manage their patients’ condition in an optimal way. Today, the Accu-Chek portfolio offers people with diabetes and healthcare professionals innovative products and impactful solutions for convenient, efficient and effective diabetes management, spanning from blood glucose monitoring through information management to insulin delivery. The Accu-Chek brand encompasses blood glucose meters, insulin delivery systems, lancing devices, data management systems and education programs – contributing to an improved medical outcome.

Additional information:

Open letter from the founders:
Management team:

mySugr Inc
111 C Street
Encinitas, CA 92024

Press contact
Sara Westermann
Phone: +1 760 557 9825

Record changed: 2023-06-05


Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x200px

More documents for Roche (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group BIO-Europe 2023 Munich BEU23 650x300px

» top